Award
NIH Reporter #1R01CA304003-01A1
Movement is medicine in multiple myeloma: elucidating exercise-mediated immune and metabolic biomarkers that predict treatment response in the bone marrow tumor microenvironment
Recipient
ROSWELL PARK CANCER INSTITUTE CORP
Award Amount
$718,490.00
Ceiling
$718,490.00
Awarded
September 16, 2026
Identifier
1R01CA304003-01A1
NIH/NCI awarded a research project to study exercise-mediated immune and metabolic biomarkers in multiple myeloma to predict treatment response in the bone marrow tumor microenvironment.
Description
This is a research project funded by the NIH/NCI focusing on exercise interventions in multiple myeloma patients, with a detailed study plan involving immune and metabolomic biomarkers, machine learning, and clinical trials.